Roy C. Hardiman's Net Worth
$13 Million
Who is Roy C. Hardiman?
Roy C. Hardiman has an estimated net worth of $13 Million. This is based on reported shares across multiple companies, which include Principia Biopharma Inc., PHARMACYCLICS INC, and ALUMIS INC..
SEC CIK
Roy C. Hardiman's CIK is 0001506218
Past Insider Trading and Trends
2024 was Roy C. Hardiman's most active year for acquiring shares with 7 total transactions. Roy C. Hardiman's most active month to acquire stocks was the month of June. 2020 was Roy C. Hardiman's most active year for disposing of shares, totalling 16 transactions. Roy C. Hardiman's most active month to dispose stocks was the month of August. 2020 saw Roy C. Hardiman paying a total of $76,556.53 for 70,000 shares, this is the most they've acquired in one year. In 2020 Roy C. Hardiman cashed out on 318,314 shares for a total of $12,824,621.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Principia Biopharma Inc. No price found
Chief Business OfficerRoy C. Hardiman used to own units in Common Stock but no longer holds any shares there.acquired a total of 20,000 shares in Principia Biopharma Inc. at a cost of $101,299.69, Roy also disposed a total of 137,761 shares of Principia Biopharma Inc. equalling to $13,071,655.53.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -119.68K |
$100.00 | -$11,967,700.00 |
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
$52.92 | -$470,596.97 | 117.76K |
Scheduled
|
Sep 18
| ||
Form 4
|
—
|
0
|
$32.94 | -$282,170.38 | 117.76K |
Scheduled
|
Jun 12
| ||
Form 4
|
—
|
0
|
$26.64 | -$219,197.80 | 116.9K |
Scheduled
|
Mar 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
—
|
0
|
$27.18 | -$222,290.71 | 120.14K |
Scheduled
|
Dec 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PHARMACYCLICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9 - Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ALUMIS INC. No price found
Chief Business & Legal OfficerRoy C. Hardiman owns 175,401 units of Common Stock. Roy C. Hardiman used to own units in Class A Common Stock but no longer holds any shares there. In the year 2024 Roy C. Hardiman filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 181.82K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |